Literature DB >> 21982835

Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.

Felipe Fernández-Cuenca, José Manuel Rodríguez-Martínez, M A Carmen Gómez-Sánchez, Paula Díaz de Alba, Vanesa Infante-Martínez, Alvaro Pascual.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982835     DOI: 10.1016/j.ijantimicag.2011.07.017

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  5 in total

1.  OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain.

Authors:  Rodrigo Cayô; María Merino; Belén Ruiz Del Castillo; María Eliecer Cano; Jorge Calvo; Germán Bou; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

2.  First report of Oxa-72-producing Acinetobacter calcoaceticus in Lebanon.

Authors:  A Al Atrouni; M Kempf; M Eveillard; R Rafei; M Hamze; M-L Joly-Guillou
Journal:  New Microbes New Infect       Date:  2015-11-23

3.  Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.

Authors:  Ashika Singh-Moodley; Olga Perovic
Journal:  BMC Infect Dis       Date:  2016-10-04       Impact factor: 3.090

4.  Evaluation of Combined Use of Temocillin Disk and Mastdisks Inhibitor Combination Set Against Polymerase Chain Reaction for Detection of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Omnia A Shaker; Howayda E Gomaa; Shereen A ElMasry; Rania M Abdel Halim; Amany H Abdelrahman; Jackline S Kamal
Journal:  Open Access Maced J Med Sci       Date:  2018-02-01

5.  Acinetobacter baumannii infections in Amazon Region driven by extensively drug resistant international clones, 2016-2018.

Authors:  Raquel Vosges Caldart; Erica L Fonseca; Fernanda Freitas; Luiza Rocha; Ana Carolina Vicente
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-11-25       Impact factor: 2.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.